Other News To Note
Wednesday, June 20, 2012
Bavarian Nordic A/S, of Kvistgaard, Denmark, received a $17.9 million five-year contract from the National Institute of Allergy and Infectious Diseases to support development of candidate vaccine technologies to combat the intentional release of pathogens considered a threat to public health.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.